Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Neupath Health Inc. ( (TSE:NPTH) ) has shared an update.
NeuPath Health Inc. announced it will release its Q2 2025 financial results on August 14, 2025, before the market opens. The company will host a live investor webinar on August 21, 2025, featuring CEO Joe Walewicz, to discuss the results and strategic outlook. This announcement is part of NeuPath’s efforts to enhance transparency and engage with stakeholders, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (TSE:NPTH) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Neupath Health Inc. stock, see the TSE:NPTH Stock Forecast page.
More about Neupath Health Inc.
NeuPath Health Inc. operates a network of healthcare clinics in Ontario and Alberta, focusing on chronic pain treatment, musculoskeletal injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments, along with contract research services for pharmaceutical and biotechnology companies.
Average Trading Volume: 83,750
Technical Sentiment Signal: Buy
Current Market Cap: C$13.12M
See more data about NPTH stock on TipRanks’ Stock Analysis page.